Literature DB >> 33876200

Surface-in pathology in multiple sclerosis: a new view on pathogenesis?

Matteo Pardini1,2, J William L Brown1,3,4, Roberta Magliozzi5,6, Richard Reynolds6,7, Declan T Chard1,8.   

Abstract

While multiple sclerosis can affect any part of the CNS, it does not do so evenly. In white matter it has long been recognized that lesions tend to occur around the ventricles, and grey matter lesions mainly accrue in the outermost (subpial) cortex. In cortical grey matter, neuronal loss is greater in the outermost layers. This cortical gradient has been replicated in vivo with magnetization transfer ratio and similar gradients in grey and white matter magnetization transfer ratio are seen around the ventricles, with the most severe abnormalities abutting the ventricular surface. The cause of these gradients remains uncertain, though soluble factors released from meningeal inflammation into the CSF has the most supporting evidence. In this Update, we review this 'surface-in' spatial distribution of multiple sclerosis abnormalities and consider the implications for understanding pathogenic mechanisms and treatments designed to slow or stop them.
© The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  B cell follicle; magnetization transfer ratio; meningeal inflammation; multiple sclerosis; neuropathology

Year:  2021        PMID: 33876200     DOI: 10.1093/brain/awab025

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  12 in total

Review 1.  Emerging therapies to target CNS pathophysiology in multiple sclerosis.

Authors:  Jiwon Oh; Amit Bar-Or
Journal:  Nat Rev Neurol       Date:  2022-06-13       Impact factor: 44.711

2.  Periventricular gradient of T1 tissue alterations in multiple sclerosis.

Authors:  Manuela Vaneckova; Gian Franco Piredda; Michaela Andelova; Jan Krasensky; Tomas Uher; Barbora Srpova; Eva Kubala Havrdova; Karolina Vodehnalova; Dana Horakova; Tom Hilbert; Bénédicte Maréchal; Mário João Fartaria; Veronica Ravano; Tobias Kober
Journal:  Neuroimage Clin       Date:  2022-04-16       Impact factor: 4.891

3.  BTK inhibition limits B-cell-T-cell interaction through modulation of B-cell metabolism: implications for multiple sclerosis therapy.

Authors:  Rui Li; Hao Tang; Jeremy C Burns; Brian T Hopkins; Carole Le Coz; Bo Zhang; Isabella Peixoto de Barcelos; Neil Romberg; Amy C Goldstein; Brenda L Banwell; Eline T Luning Prak; Michael Mingueneau; Amit Bar-Or
Journal:  Acta Neuropathol       Date:  2022-03-18       Impact factor: 15.887

Review 4.  Thinking outside the box: non-canonical targets in multiple sclerosis.

Authors:  Laura Bierhansl; Hans-Peter Hartung; Orhan Aktas; Tobias Ruck; Michael Roden; Sven G Meuth
Journal:  Nat Rev Drug Discov       Date:  2022-06-06       Impact factor: 112.288

5.  Repurposing Histaminergic Drugs in Multiple Sclerosis.

Authors:  Susanna Amadio; Federica Conte; Giorgia Esposito; Giulia Fiscon; Paola Paci; Cinzia Volonté
Journal:  Int J Mol Sci       Date:  2022-06-06       Impact factor: 6.208

Review 6.  Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics.

Authors:  Emily Kamma; Wendy Lasisi; Cole Libner; Huah Shin Ng; Jason R Plemel
Journal:  J Neuroinflammation       Date:  2022-02-10       Impact factor: 8.322

7.  Single-cell profiling reveals periventricular CD56bright NK cell accumulation in multiple sclerosis.

Authors:  Sabela Rodríguez-Lorenzo; Lynn van Olst; Carla Rodriguez-Mogeda; Alwin Kamermans; Susanne M A van der Pol; Ernesto Rodríguez; Gijs Kooij; Helga E de Vries
Journal:  Elife       Date:  2022-05-10       Impact factor: 8.713

8.  Choroid plexus volume in multiple sclerosis predicts expansion of chronic lesions and brain atrophy.

Authors:  Samuel Klistorner; Michael H Barnett; John Parratt; Con Yiannikas; Stuart L Graham; Alexander Klistorner
Journal:  Ann Clin Transl Neurol       Date:  2022-09-03       Impact factor: 5.430

9.  Inhibitory synaptic loss drives network changes in multiple sclerosis: An ex vivo to in silico translational study.

Authors:  Marijn Huiskamp; Svenja Kiljan; Shanna Kulik; Maarteen E Witte; Laura E Jonkman; John Gjm Bol; Geert J Schenk; Hanneke E Hulst; Prejaas Tewarie; Menno M Schoonheim; Jeroen Jg Geurts
Journal:  Mult Scler       Date:  2022-10-03       Impact factor: 5.855

Review 10.  The emerging roles of piezo1 channels in animal models of multiple sclerosis.

Authors:  Kai Yang; Xueai He; Zhengqi Wu; Yimeng Yin; Hanyu Pan; Xinyue Zhao; Taolei Sun
Journal:  Front Immunol       Date:  2022-09-13       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.